ACTInium-J591 Radionuclide Therapy in PSMA-Detected Metastatic HOrmone-Sensitive Recurrent Prostate CaNcer

NCT05567770 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Stakeholder elected not to proceed with the study

Conditions

Prostate Cancer Metastatic

Interventions

DRUG: Actinium-J591
RADIATION: Stereotactic Body Radiation Therapy
DRUG: Androgen Deprivation Therapy

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]